Eptifibatide
- Product NDC
- 70436-162
- 11-digit product format
- 704360162
- Labeler code
- 70436
- Product ID
- 70436-162_4a614df8-4e1d-d610-e063-6294a90a7d7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eptifibatide
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Slate Run Pharmaceuticals, LLC
- Application
- ANDA209864
- Marketing category
- ANDA
- Marketing start
- 2019-06-01
- Substance
- EPTIFIBATIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eptifibatide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EPTIFIBATIDE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NA8320J834 |
| Rxcui | 200349, 1736470 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70436-162-80 | Eptifibatide | 10 mL in 1 VIAL | INJECTION | 10 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70436-162 | EPTIFIBATIDE INJECTION [SLATE RUN PHARMACEUTICALS, LLC] | 5 | Current NDC, Legacy NDC, 1 package rows | 20221125_2ab98ecd-c578-4032-a3d5-ae14d58d86a7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70436-162-80 | 70436016280 | 10 mL in 1 VIAL (70436-162-80) | 10 ml | 2020-12-01 | 0000-00-00 | No | No | Current |